Valuation: Danaher Corporation

Capitalization 166B 141B 131B 122B 228B 15,251B 242B 1,496B 594B 7,201B 622B 610B 26,194B P/E ratio 2025 *
45.1x
P/E ratio 2026 * 34.5x
Enterprise value 179B 153B 141B 132B 246B 16,483B 261B 1,616B 642B 7,783B 673B 659B 28,310B EV / Sales 2025 *
7.32x
EV / Sales 2026 * 6.9x
Free-Float
72.69%
Yield 2025 *
0.53%
Yield 2026 * 0.58%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.11%
1 week-0.42%
Current month+2.66%
1 month+1.81%
3 months+5.51%
6 months+18.76%
Current year+2.66%
More quotes
1 week 231.1
Extreme 231.1
242.8
1 month 227.23
Extreme 227.23
242.8
Current year 227.23
Extreme 227.23
242.8
1 year 171
Extreme 171
258.23
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO 54 01/01/2019
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1983
Director/Board Member 69 01/01/1983
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.11%-0.42%-4.34%-15.16% 166B
-2.11%+1.17%+8.89%+3.50% 235B
-0.35%-2.06%-13.91%+104.70% 186B
+1.34%+5.04%-8.98%+101.77% 137B
-1.84%-6.48%-20.32%-11.63% 56.8B
-0.92%-0.82%+21.37%+4.50% 48.55B
-2.58%-3.29%-11.41%-15.09% 38.29B
-2.59%-2.42%-9.52%+14.74% 36.34B
-1.16%-2.02%+1.41%+6.70% 36.76B
+1.04%-2.82%-16.21%-42.67% 33.96B
Average -1.13%-1.19%-5.30%+15.13% 97.48B
Weighted average by Cap. -1.10%+0.06%-3.94%+30.80%
See all sector performances

Financials

2025 *2026 *
Net sales 24.52B 20.86B 19.33B 18.07B 33.68B 2,253B 35.7B 221B 87.72B 1,064B 91.96B 90.08B 3,870B 25.51B 21.69B 20.11B 18.79B 35.03B 2,343B 37.13B 230B 91.23B 1,106B 95.64B 93.68B 4,025B
Net income 3.7B 3.15B 2.92B 2.73B 5.09B 340B 5.39B 33.37B 13.25B 161B 13.89B 13.6B 584B 4.83B 4.1B 3.8B 3.55B 6.63B 443B 7.02B 43.47B 17.26B 209B 18.09B 17.72B 761B
Net Debt 13.41B 11.41B 10.57B 9.88B 18.42B 1,232B 19.52B 121B 47.97B 582B 50.29B 49.26B 2,116B 9.92B 8.43B 7.82B 7.31B 13.62B 911B 14.44B 89.35B 35.47B 430B 37.19B 36.43B 1,565B
More financial data * Estimated data
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (41% of net sales); - life sciences equipment (30.7%); - biotechnology equipment (28.3%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (41.6%), China (11.7%) and other (46.7%).
Employees
62,000
More about the company
Date Price Change Volume
23/01/26 235.01 $ -2.11% 3,066,719
22/01/26 240.08 $ -0.81% 2,955,118
21/01/26 242.05 $ +3.29% 5,042,946
20/01/26 234.33 $ -0.70% 4,326,413
16/01/26 235.99 $ -1.63% 3,904,435

Delayed Quote Nyse, 24 January 2026 at 08:00 am AEDT

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
235.01USD
Average target price
263.05USD
Spread / Average Target
+11.93%
Consensus

Quarterly revenue - Rate of surprise